During the past decade, Kyorin University Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 5 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kyorin University Hospital" #1 sponsor was "Haruhiko Fukuda" with 5 trials, followed by "Galapagos NV" with 3 trials sponsored, "Pfizer" with 2 trials sponsored, "AbbVie" with 1 trials sponsored and "Boston Scientific Corporation" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kyorin University Hospital" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 5 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator, "ADIR, a Servier Group company" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Kyorin University Hospital" are "Crohn's Disease" (3 trials), "Ulcerative Colitis" (2 trials), "Acute Ischemic Stroke" (1 trials), "Advanced Cholangiocarcinoma" (1 trials) and "Alopecia Areata" (1 trials). Many other conditions were trialed in "Kyorin University Hospital" in a lesser frequency.

Most popular intervention types in "Kyorin University Hospital" are "Drug" (13 trials), "Device" (4 trials), "Procedure" (3 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Filgotinib" (4 trials), "Placebo" (4 trials), "Cisplatin" (2 trials), "3-Dimensional Conformal Radiation Therapy" (1 trials) and "5-FU/calcium levofolinate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kyorin University Hospital" are 21 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are 8 active trials in "Kyorin University Hospital". 1 are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 14 completed trials in Kyorin University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kyorin University Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".